Pluri (PLUR) Research & Development (2010 - 2025)
Pluri (PLUR) reported Research & Development of $3.9 million for Q4 2025, up 35.01% year-over-year from $2.9 million in Q4 2024, and little changed quarter-over-quarter from $3.9 million in Q3 2025.
Pluri (PLUR) Research & Development (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Research & Development data on file, last reported at $3.9 million in Q4 2025.
- Research & Development for Q4 2025 came in at $3.9 million, up 35.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.3 million (up 24.54% YoY), and the FY2025 annual result was $14.0 million, up 12.52% from the prior year.
- Research & Development was little changed at $3.9 million in Q4 2025 per PLUR's latest filing, from $3.9 million in the prior quarter.
- Over five years, Research & Development peaked at $8.5 million in Q2 2021 and troughed at -$19.0 million in Q2 2022.
- A 5-year average of $3.3 million and a median of $3.9 million in 2022 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development sank 323.08% in 2022, then soared 112.29% in 2023.
- A 5-year view of Research & Development shows it stood at $6.5 million in 2021, then sank by 42.13% to $3.8 million in 2022, then declined by 21.69% to $3.0 million in 2023, then decreased by 1.32% to $2.9 million in 2024, then surged by 35.01% to $3.9 million in 2025.
- Business Quant data shows PLUR's Research & Development at $3.9 million in Q4 2025, $3.9 million in Q3 2025, and $4.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 3.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.93 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 3.09 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 3.37 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 4.33 Mn |
| Dec 31, 2022 | 3.79 Mn |
| Sep 30, 2022 | 4.27 Mn |
| Jun 30, 2022 | -18.98 Mn |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | 6.54 Mn |
| Sep 30, 2021 | 6.35 Mn |
| Jun 30, 2021 | 8.51 Mn |
| Mar 31, 2021 | 7.67 Mn |